Tamoxifen is a potent, selective estrogen receptor (ER) antagonist. It affects PI3K/AKT and MAPK signaling pathways. By competitively binding to ER and blocking estrogen-dependent transcription, it effectively inhibits breast cancer cell proliferation and promotes apoptosis.
Tamoxifen IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Tamoxifen Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Tamoxifen Mechanism of Action: Estrogen Receptor (ER) Inhibition in Breast Cancer Cell Research
- Tamoxifen Clinical Trials
- Tamoxifen: Selectivity & Specificity
- Tamoxifen Working Concentration | Cell Culture | Treatment
- Tamoxifen Solubility in DMSO
- Tamoxifen Storage
- Tamoxifen Stability
- Tamoxifen Combination Database
- Tamoxifen Molecular Weight
- Tamoxifen SMILES
- Tamoxifen CAS Number
- Tamoxifen Chemical Structure (2D and 3D)
- Tamoxifen Sigma (t5648)? Try a better option.
- Tamoxifen MedChemExpress (HY-13757A)? Try a better option.
- Tamoxifen Cayman (13258)? Try a better option.
- Tamoxifen APExBIO (B5421)? Try a better option.
- Tamoxifen SDS｜MSDS